These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11063348)

  • 21. A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients.
    Hardinger KL; Bohl DL; Schnitzler MA; Lockwood M; Storch GA; Brennan DC
    Transplantation; 2005 Jul; 80(1):41-6. PubMed ID: 16003231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute rejection in non-compliant renal allograft recipients: a distinct morphology.
    Lerut E; Kuypers DR; Verbeken E; Cleutjens J; Vlaminck H; Vanrenterghem Y; Van Damme B
    Clin Transplant; 2007; 21(3):344-51. PubMed ID: 17488383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication compliance after renal transplantation.
    Hilbrands LB; Hoitsma AJ; Koene RA
    Transplantation; 1995 Nov; 60(9):914-20. PubMed ID: 7491693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should Pre-Transplant Hemoglobin A1c Be Used to Predict Post-Transplant Compliance in End-Stage Renal Disease Patients Undergoing Kidney Transplantation?
    Terranella SL; Poirier J; Chan EY; Hertl M; Olaitan OK
    Ann Transplant; 2020 Jun; 25():e924061. PubMed ID: 32587234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved clinical outcomes in Chinese renal allograft recipients receiving lower dose immunosuppressants.
    Wu JY; Chen JH; Wang YM; He Q; Wu DB
    Transplantation; 2004 Sep; 78(5):713-8. PubMed ID: 15371674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interaction between sildenafil and calcineurin inhibitors in renal transplant recipients with erectile dysfunction].
    Cofán F; Gutiérrez R; Beardo P; Campistol JM; Oppenheimer F; Alcover J
    Nefrologia; 2002; 22(5):470-6. PubMed ID: 12497749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Trough Levels of Tacrolimus on Kidney Function and Graft Survival in Short and Longer Periods After Renal Transplantation.
    Žilinská Z; Dedinská I; Breza J; Laca L
    Transplant Proc; 2016 Oct; 48(8):2637-2643. PubMed ID: 27788794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients.
    Birkeland SA
    Transplantation; 2001 Apr; 71(8):1089-90. PubMed ID: 11374407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Satisfaction and adherence with immunosuppressant treatment in renal transplant patients living with a working graft.
    Ortega F; Otero A; Crespo JF; Delgado JF; Borro JM; Cuervo J;
    J Nephrol; 2013; 26(2):297-305. PubMed ID: 22684646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients.
    Peng ZG; Tian J
    Clin Transpl; 2014; ():209-14. PubMed ID: 26281147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
    Viesselmann CW; Descourouez JL; Jorgenson MR; Radke NA; Odorico JS
    Pharmacotherapy; 2016 Mar; 36(3):335-41. PubMed ID: 26877191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
    Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is noncompliance among adolescent renal transplant recipients inevitable?
    Feinstein S; Keich R; Becker-Cohen R; Rinat C; Schwartz SB; Frishberg Y
    Pediatrics; 2005 Apr; 115(4):969-73. PubMed ID: 15805372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compliance with cyclosporine in adolescent renal transplant recipients.
    Blowey DL; Hébert D; Arbus GS; Pool R; Korus M; Koren G
    Pediatr Nephrol; 1997 Oct; 11(5):547-51. PubMed ID: 9323277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pill burden does not influence compliance with oral medication in recipients of renal transplant.
    Adhikari UR; Taraphder A; Hazra A; Das T
    Indian J Pharmacol; 2016; 48(1):21-5. PubMed ID: 26997717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
    Dudley CR;
    Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of sirolimus in combination with low-dose cyclosporine and steroids on acute renal allograft rejection.
    Tsai MK; Chueh SC; Hu RH; Lee PH
    J Formos Med Assoc; 2003 Feb; 102(2):91-6. PubMed ID: 12709737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression.
    Pinsky BW; Takemoto SK; Lentine KL; Burroughs TE; Schnitzler MA; Salvalaggio PR
    Am J Transplant; 2009 Nov; 9(11):2597-606. PubMed ID: 19843035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is age associated with the number or types of medications prescribed to renal transplant recipients?
    Chisholm MA; Melroy J; Johnson M; Mulloy LL; Spivey CA
    J Am Geriatr Soc; 2007 Mar; 55(3):389-94. PubMed ID: 17341241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.